Jon Isaacsohn
Geen lopende functies
Profiel
The founder of CinCor Pharma, Inc. is Jon Isaacsohn.
He held the titles of Director and Chief Scientific Officer at the company in 2021.
Eerdere bekende functies van Jon Isaacsohn
| Bedrijven | Functie | Einde |
|---|---|---|
| CINCOR PHARMA, INC. | Algemeen Directeur | 06-07-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |